Risk factors for anthracycline-associated cardiotoxicity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk factors for anthracycline-associated cardiotoxicity

Published:2015-11-12 Issue:5 Volume:24 Page:2173-2180
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Reinbolt Raquel E.,Patel Roshan,Pan Xueliang,Timmers Cynthia Dawn,Pilarski Robert,Shapiro Charles L.,Lustberg Maryam B.

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-015-3008-y.pdf

Reference37 articles.

1. Buzdar AU, Marcus C, Smith TL, Blumenschein GR (1985) Early and delayed clinical cardiotoxicity of doxorubicin. Cancer 55(12):2761–2765

2. Swain SM, Whaley FS, Ewer MS (2003) Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 97(11):2869–2879. doi: 10.1002/cncr.11407

3. Singal PK, Iliskovic N (1998) Doxorubicin-induced cardiomyopathy. N Engl J Med 339(13):900–905. doi: 10.1056/NEJM199809243391307

4. Kremer LC, van Dalen EC, Offringa M, Ottenkamp J, Voute PA (2001) Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study. J Clin Oncol: Off J Am Soc Clin Oncol 19(1):191–196

5. Von Hoff DD, Layard MW, Basa P, Davis HL Jr, Von Hoff AL, Rozencweig M, Muggia FM (1979) Risk factors for doxorubicin-induced congestive heart failure. Ann Intern Med 91(5):710–717

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential cardioprotective effect of Ganoderma lucidum against 5-fluorouracil cardiotoxicity;Review of Clinical Pharmacology and Pharmacokinetics - International Edition;2024-08-04

2. Smoking, Diabetes Mellitus, and Previous Cardiovascular Disease as Predictors of Anticancer Treatment-Induced Cardiotoxicity in Non–Small-Cell Lung Cancer: A Real-World Study;Clinical Lung Cancer;2024-01

3. Cardiac Toxicities in Oncology: Elucidating the Dark Box in the Era of Precision Medicine;Current Issues in Molecular Biology;2023-10-15

4. Omics Technologies Improving Breast Cancer Research and Diagnostics;International Journal of Molecular Sciences;2023-08-11

5. New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review;Cancers;2023-06-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3